Drug Discovery

Funding will accelerate development of the company’s AI-powered antibody drug discovery technology, focused on identifying new therapeutics for cancer, heart, and lung diseases

Vipergen’s Cellular Binder Trap Enrichment® (cBTE) technology provides a robust system to accelerate and improve drug discovery

Through end-to-end automation, the company’s unique technology platform rapidly delivers reliable, reproducible, and fully auditable datasets

Collaboration combines Sosei Heptares’ leading structure-based drug design platform with Metrion Biosciences’ ion channel expertise

MOBILion Systems and Protein Metrics join forces to integrate the Byos® Software Suite with high-resolution ion mobility mass spectrometry

Endeavor revolutionizes drug discovery by delivering high speed, high resolution, full-well scanning of cell-based assays

New features include reaction-based library enumeration for novel molecule generation and optimization

Study should significantly facilitate research into the promising substance

FDA publication demonstrates advantages of PhysioMimix in drug safety and metabolism applications over standard techniques